An empirical Bayes approach to evaluation of results for a specific region in multiregional clinical trials

Yufen Huang, Wan Jung Chang, Chin Fu Hsiao

Research output: Contribution to journalArticlepeer-review

4 Citations (Scopus)

Abstract

To accelerate the drug development process and shorten approval time, the design of multiregional clinical trials (MRCTs) incorporates subjects from many countries/regions around the world under the same protocol. After showing the overall efficacy of a drug in all global regions, one can also simultaneously evaluate the possibility of applying the overall trial results to all regions and subsequently support drug registration in each of them. In this paper, we focus on a specific region and establish a statistical criterion to assess the consistency between the specific region and overall results in an MRCT. More specifically, we treat each region in an MRCT as an independent clinical trial, and each perhaps has different treatment effect. We then construct the empirical prior information for the treatment effect for the specific region on the basis of all of the observed data from other regions. We will conclude similarity between the specific region and all regions if the posterior probability of deriving a positive treatment effect in the specific region is large, say 80%. Numerical examples illustrate applications of the proposed approach in different scenarios.

Original languageEnglish
Pages (from-to)59-64
Number of pages6
JournalPharmaceutical Statistics
Volume12
Issue number2
DOIs
Publication statusPublished - 2013 Mar

All Science Journal Classification (ASJC) codes

  • Statistics and Probability
  • Pharmacology
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'An empirical Bayes approach to evaluation of results for a specific region in multiregional clinical trials'. Together they form a unique fingerprint.

Cite this